Stroke Nervous System Diseases
Conditions
Interventions
The study is a mixed-methods feasibility study with two phases:
Phase 1: Co-design workshops actively collaborating with stakeholders to design a training programme for CarePartners to deliver mobiliz
Sponsors
Keele University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Phase 1: Months 0-6 1. Adult (18 years old or more) stroke survivors (SSs) with ongoing self-reported UL dysfunction, discharged from hospital inpatient care. Interpreters will be sourced as required 2. Adult (18 years old or more) informal carers of SSs discharged from hospital care. Interpreters will be sourced as required. 3. Physiotherapists at NHS Band 6 or above who have two or more years’ experience working in community or outpatient stroke services Phase 2: Feasibility study - months 6-30 1. Adult (18 years of age or more) SS and CarePartner pairs, where: 1.1. The SS has ongoing UL dysfunction because of stroke (score of <33; the maximum score representing ‘normal’ strength, i.e. comparable to ‘nonparetic’ limb on the Motricity Index UL section, measuring muscle strength at shoulder, elbow and hand) 1.2. SS discharged from inpatient care 1.3. SS willing to receive CarePartner-delivered MTS 1.4. Both SS and CarePartner are willing and have the capacity to consent to participating in the trial 1.5. CarePartner willing and able to be trained 1.6. CarePartner willing to commit to deliver MTS to their SS’s UL at home, according to protocol
Exclusion criteria
Exclusion criteria: Phase 1: Months 0-6 1. SSs who have severe aphasia, meaning they are unable to contribute to discussions unless they have an alternative means of communicating effectively (e.g. communication board, technology, signing) 2. Informal carers who are unable to contribute to discussions unless they have an alternative means of communicating effectively (e.g. communication board, technology, signing) Phase 2: Feasibility study - months 6-30 1. SS-CarePartner pairs if one of the pair does not consent, or if the SS has no CarePartner available to take part 2. SS-CarePartner pairs if the CarePartner has significant health conditions, e.g. upper-limb dysfunction (from a neurological, orthopaedic, e.g. severe OA or RA of the hands, or other condition that might be exacerbated) affecting their ability to deliver MTS The study will record the number and nature of exclusions to inform future plans for greater inclusivity
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The Action Research Arm Test (measuring hemiparetic upper limb activity limitation) is anticipated to be the primary outcome measure; however, as this is a feasibility study, one of the purposes of the study is to ascertain the most appropriate primary outcome measure to take forward to a larger study in the future. The primary outcome will be assessed at baseline, after the six-week intervention and at three months | — |
Secondary
| Measure | Time frame |
|---|---|
| The following secondary outcomes are assessed at baseline, after the six-week intervention and at three months: Walking (activity limitation) will be measured using: 1. Able to walk 10 m independently (walking aids permitted)? Y/N 2. Timed 10 m walk test, at a comfortable pace, if able to walk 10m independently Body function and structure will be measured using: Motricity Index (arm section) Hemiparetic hand sensation will be measured using: Nottingham Sensory Assessment – tactile and kinaesthetic subsections only CarePartner burden will be measured using: Zarit burden interview | — |
Countries
England, United Kingdom
Contacts
Public ContactAli Aries
Outcome results
None listed